Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| PTC THERAPEUTICS, INC.PTCT · Entity 3803 | Director | February 15, 2024 | February 16, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
PTC THERAPEUTICS, INC.
Report date February 15, 2024 · Filed February 16, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 10,333 |
Reported balance
After 2024-02-15 transaction · row 1
1 source rowRow 1 · 2024-02-15 · Grant · Acquired 4,000 · Balance 10,333 F1: Restricted stock units granted on February 15, 2024 that vest over one year, with one-third (1/3) of the shares underlying the RSUs vesting on June 18, 2024 and the remaining two-thirds (2/3) of the original shares underlying the RSUs vesting on February 15, 2025. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $25.69 · Expires 2034-02-14 | Direct | 10,000 |
Reported balance
After 2024-02-15 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2024-02-15 · Grant · Acquired 10,000 · Balance 10,000 F2: This option was granted on February 15, 2024 and vests over one year in twelve equal monthly installments, commencing on March 15, 2024. |
Filing footnotes · ownership attribution and instrument terms
F1: Restricted stock units granted on February 15, 2024 that vest over one year, with one-third (1/3) of the shares underlying the RSUs vesting on June 18, 2024 and the remaining two-thirds (2/3) of the original shares underlying the RSUs vesting on February 15, 2025.
F2: This option was granted on February 15, 2024 and vests over one year in twelve equal monthly installments, commencing on March 15, 2024.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 15, 2024 Filed Feb 16, 2024 21:20 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | GrantStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $25.69 | $0.00 |
DisclosureSEC source: 0001415889-24-004122 · form4-02162024_040204.xml · derivative · entry 2 Bell William F. Jr. · CIK 0001980122 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2034-02-14 F2 · derivative.exercise_date: This option was granted on February 15, 2024 and vests over one year in twelve equal monthly installments, commencing on March 15, 2024. Read SEC document |
| February 15, 2024 Filed Feb 16, 2024 21:20 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | GrantCommon Stock | 4,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-004122 · form4-02162024_040204.xml · nonDerivative · entry 1 Bell William F. Jr. · CIK 0001980122 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,333 F1 · shares: Restricted stock units granted on February 15, 2024 that vest over one year, with one-third (1/3) of the shares underlying the RSUs vesting on June 18, 2024 and the remaining two-thirds (2/3) of the original shares underlying the RSUs vesting on February 15, 2025. Read SEC document |
| June 06, 2023 Filed Jun 7, 2023 20:07 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | GrantStock Option (Right to Buy) · Derivative | 5,834 | $0.00 Strike: $45.02 | $0.00 |
DisclosureSEC source: 0001415889-23-009356 · form4-06072023_080617.xml · derivative · entry 4 Bell William F. Jr. · CIK 0001980122 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,834 Underlying: Common Stock · 5,834 shares Expires 2033-06-05 F4 · derivative.exercise_date: This option was granted on June 6, 2023 and vests over seven approximately equal monthly installments, commencing on July 5, 2023. Read SEC document |
| June 06, 2023 Filed Jun 7, 2023 20:07 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | GrantStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $45.02 | $0.00 |
DisclosureSEC source: 0001415889-23-009356 · form4-06072023_080617.xml · derivative · entry 3 Bell William F. Jr. · CIK 0001980122 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2033-06-05 F3 · derivative.exercise_date: This option was granted on June 6, 2023 and vests over thirty-six approximately equal monthly installments, commencing on July 6, 2023. Read SEC document |
| June 06, 2023 Filed Jun 7, 2023 20:07 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | GrantCommon Stock | 2,333 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-009356 · form4-06072023_080617.xml · nonDerivative · entry 2 Bell William F. Jr. · CIK 0001980122 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,333 F2 · shares: Restricted stock units granted on June 6, 2023 that vest on January 5, 2024. Read SEC document |
| June 06, 2023 Filed Jun 7, 2023 20:07 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | GrantCommon Stock | 4,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-009356 · form4-06072023_080617.xml · nonDerivative · entry 1 Bell William F. Jr. · CIK 0001980122 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,000 F1 · shares: Restricted stock units granted on June 6, 2023 that vest in three equal installments over three years, commencing on June 6, 2024. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.